All In MedTech

Device Trial Radar · NCT05844826

Evaluation of the Microbiome in Multiple Sclerosis

A Clinical Study To Evaluate Small Intestine Microbiome In Multiple Sclerosis (MS)

Last checked: Nov 20, 2026Latest source record: May 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

40

Actual

Start

Jun 26, 2023

Primary completion

Apr 24, 2024

Study completion Apr 24, 2024

Sponsor

Lead sponsor
Nimble Science Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
IGY Life Sciences
First posted
May 6, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To access the small intestinal microbiome and find abnormal microbiome/metabolome signature in luminal fluid samples from small bowel in MS compared to HC that could be used as biomarkers for MS.

Conditions

  • Multiple Sclerosis

Interventions

  • SIMBA CapsuleDevice

    Participants will swallow capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 16s microbiome sequencing and LC-MS metabolomic analysis will be performed on these samples to compare gut microbiome and metabolite profiles of healthy control and diagnosed MS patientsTime frame: baseline
  2. Comparison of blood samples from Multiple Sclerosis (MS) and healthy control participants for biomarkers of inflammation, as analysed using ELISA, protenomic methods, and commercially available assays.Time frame: baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Calgary

    Calgary, Alberta, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.